Anne Assmus Headshot.png

Anne Assmus, PhD

Dr. Anne Assmus is a highly-experienced deal maker in the Biotech field, drawing on significant experience in establishing collaboration, licensing and M&A deals, in financial analysis and valuation.

Anne has over 10 years of international experience in biotech business development and strategic consulting with a focus on oncology. Prior to joining Virogin Biotech Ltd, Anne worked as VP of Affimed NV, a clinical stage biopharmaceutical company developing immune cell engaging bispecific antibodies in hematological malignancies, as Senior Consultant at a Boston-based boutique consultancy, was Senior Manager of Business Development at Immatics Biotechnologies GmbH, Tuebingen, Germany, a cancer-focused peptide-MHC identification, vaccines and T-cell therapy company. Before Immatics, she was Manager of Business Development at MorphoSys AG, Munich, Germany, one of the world’s leading antibody technology companies, and Marketing Analyst at Novozymes A/S, Bagsvaerd, Denmark.

Anne also manages a foundation that supports research in neuro-oncology in German speaking countries. She is a Research Affiliate and holds a PhD in Economics from the University of Passau, holds a Master’s degree in Biology from Heidelberg University, both in Germany, and a BSc in International Business from Copenhagen Business School, Denmark.

Contact Anne at aassmus@virogin.com